Log in
NYSE:SYK

Stryker Stock Forecast, Price & News

$234.78
+0.52 (+0.22 %)
(As of 12/3/2020 12:00 AM ET)
Add
Compare
Today's Range
$232.90
Now: $234.78
$236.37
50-Day Range
$202.01
MA: $223.26
$240.31
52-Week Range
$124.54
Now: $234.78
$242.51
Volume1.07 million shs
Average Volume1.67 million shs
Market Capitalization$88.23 billion
P/E Ratio55.77
Dividend Yield0.98%
Beta0.78
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Stryker logo

Beat the Market (BTM) Rank

Analyst Opinion: 2.3Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.02 out of 5 stars


Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600
Employees40,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.88 billion
Cash Flow$11.13 per share
Book Value$34.23 per share

Profitability

Net Income$2.08 billion

Miscellaneous

Market Cap$88.23 billion
Next Earnings Date1/26/2021 (Estimated)
OptionableOptionable
$234.78
+0.52 (+0.22 %)
(As of 12/3/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Stryker (NYSE:SYK) Frequently Asked Questions

How has Stryker's stock price been impacted by COVID-19 (Coronavirus)?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, SYK shares have increased by 33.7% and is now trading at $234.78.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Stryker?

27 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last year. There are currently 2 sell ratings, 9 hold ratings, 15 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Stryker
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Stryker?

Wall Street analysts have given Stryker a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's winning trading ideas this year have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Stryker wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Tuesday, January 26th 2021.
View our earnings forecast for Stryker
.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) issued its earnings results on Thursday, October, 29th. The medical technology company reported $2.14 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.40 by $0.74. The medical technology company had revenue of $3.74 billion for the quarter, compared to the consensus estimate of $3.41 billion. Stryker had a net margin of 11.38% and a return on equity of 20.53%. The company's revenue for the quarter was up 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.91 EPS.
View Stryker's earnings history
.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Wednesday, December 2nd. Shareholders of record on Thursday, December 31st will be paid a dividend of $0.63 per share on Friday, January 29th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.07%. This is a boost from Stryker's previous quarterly dividend of $0.58.
View Stryker's dividend history
.

What price target have analysts set for SYK?

27 Wall Street analysts have issued 12-month target prices for Stryker's shares. Their forecasts range from $150.00 to $258.00. On average, they anticipate Stryker's share price to reach $221.44 in the next twelve months. This suggests that the stock has a possible downside of 5.7%.
View analysts' price targets for Stryker
.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), The Walt Disney (DIS), The Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 55, Pay $4.37M)
  • Mr. Timothy J. Scannell, Pres & COO (Age 55, Pay $2.06M)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 58, Pay $1.65M)
  • Mr. Robert S. Fletcher, VP & Chief Legal Officer (Age 49, Pay $831.18k)
  • Mr. Viju S. Menon, Group Pres of Global Quality & Operations (Age 52, Pay $1.26M)
  • Mr. Robert C. Cohen, CTO and VP of Global R&D - Joint Replacement
  • Mr. Preston Wells, VP of Investor Relations
  • Ms. Bronwen R. Taylor, VP of Compliance & Risk Management
  • Ms. Yin C. Becker, VP of Communications, Public Affairs & Corp. Marketing (Age 56)
  • Ms. M. Kathryn Fink, VP & Chief HR Officer (Age 50)

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by a variety of institutional and retail investors. Top institutional investors include BlackRock Inc. (6.88%), Greenleaf Trust (5.58%), State Street Corp (3.66%), Massachusetts Financial Services Co. MA (1.47%), Morgan Stanley (0.77%) and Wells Fargo & Company MN (0.68%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker.
View institutional ownership trends for Stryker
.

Which major investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including CIBC Private Wealth Group LLC, First Trust Advisors LP, State Street Corp, Wells Fargo & Company MN, Los Angeles Capital Management & Equity Research Inc., BlackRock Inc., Allianz Asset Management GmbH, and Massachusetts Financial Services Co. MA. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Srikant M Datar, and Timothy J Scannell.
View insider buying and selling activity for Stryker
.

Which major investors are buying Stryker stock?

SYK stock was purchased by a variety of institutional investors in the last quarter, including Alps Advisors Inc., Neuberger Berman Group LLC, DekaBank Deutsche Girozentrale, Bradley Foster & Sargent Inc. CT, Villere ST Denis J & Co. LLC, CIBC Private Wealth Group LLC, WCM Investment Management LLC, and Jensen Investment Management Inc..
View insider buying and selling activity for Stryker
.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $234.78.

How big of a company is Stryker?

Stryker has a market capitalization of $88.23 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]

This page was last updated on 12/4/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.